# Humacyte, Inc. (HUMA) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Humacyte, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/HUMA/mda/fy2025/): filed 2026-03-27; accession 0001818382-26-000004 (https://www.sec.gov/Archives/edgar/data/1818382/000181838226000004/huma-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/HUMA/mda/fy2024/): filed 2025-03-31; accession 0001818382-25-000034 (https://www.sec.gov/Archives/edgar/data/1818382/000181838225000034/huma-20241231.htm)
- [FY 2023 MD&A](/company/HUMA/mda/fy2023/): filed 2024-03-28; accession 0001818382-24-000040 (https://www.sec.gov/Archives/edgar/data/1818382/000181838224000040/huma-20231231.htm)
- [FY 2022 MD&A](/company/HUMA/mda/fy2022/): filed 2023-03-24; accession 0001818382-23-000016 (https://www.sec.gov/Archives/edgar/data/1818382/000181838223000016/huma-20221231.htm)
- [FY 2021 MD&A](/company/HUMA/mda/fy2021/): filed 2022-03-29; accession 0001818382-22-000011 (https://www.sec.gov/Archives/edgar/data/1818382/000181838222000011/huma-20211231.htm)

Back to /company/HUMA/